Biosynex SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 142.2 million compared to EUR 225.2 million a year ago. Net income was EUR 30.6 million compared to EUR 70.5 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.24 EUR | -2.85% |
|
+2.53% | -61.20% |
May. 28 | Biosynex: obtains CE markings under the new IVDR regulations | CF |
May. 13 | Biosynex: Oren Bitton appointed Chief Operating Officer | CF |
1st Jan change | Capi. | |
---|---|---|
-61.20% | 38.34M | |
-11.58% | 11.22B | |
-10.38% | 7.58B | |
+27.58% | 5.48B | |
+1.20% | 5.38B | |
-17.38% | 3.77B | |
+8.12% | 2.6B | |
-64.90% | 2.35B | |
-10.79% | 2.25B | |
+26.75% | 2.2B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2022